image
Healthcare - Medical - Devices - NASDAQ - US
$ 10.05
1 %
$ 239 M
Market Cap
-4.47
P/E
1. INTRINSIC VALUE

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.[ Read More ]

The intrinsic value of one INGN stock under the base case scenario is HIDDEN Compared to the current market price of 10.1 USD, Inogen, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart INGN

image
FINANCIALS
316 M REVENUE
-16.32%
-109 M OPERATING INCOME
-573.33%
-102 M NET INCOME
-22.30%
-3.23 M OPERATING CASH FLOW
91.38%
-59.3 M INVESTING CASH FLOW
-445.32%
960 K FINANCING CASH FLOW
152.63%
88.8 M REVENUE
0.08%
-7.79 M OPERATING INCOME
-29.11%
-5.96 M NET INCOME
-6.67%
6.99 M OPERATING CASH FLOW
4.53%
305 K INVESTING CASH FLOW
102.46%
441 K FINANCING CASH FLOW
319.40%
Balance Sheet Decomposition Inogen, Inc.
image
Current Assets 207 M
Cash & Short-Term Investments 128 M
Receivables 42.9 M
Other Current Assets 35.7 M
Non-Current Assets 119 M
Long-Term Investments 0
PP&E 70.7 M
Other Non-Current Assets 48.5 M
Current Liabilities 72.5 M
Accounts Payable 13.5 M
Short-Term Debt 7.31 M
Other Current Liabilities 51.7 M
Non-Current Liabilities 48.9 M
Long-Term Debt 18.3 M
Other Non-Current Liabilities 30.6 M
EFFICIENCY
Earnings Waterfall Inogen, Inc.
image
Revenue 316 M
Cost Of Revenue 189 M
Gross Profit 127 M
Operating Expenses 236 M
Operating Income -109 M
Other Expenses -6.94 M
Net Income -102 M
RATIOS
40.14% GROSS MARGIN
40.14%
-34.65% OPERATING MARGIN
-34.65%
-32.46% NET MARGIN
-32.46%
-50.02% ROE
-50.02%
-31.41% ROA
-31.41%
-52.53% ROIC
-52.53%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Inogen, Inc.
image
Net Income -102 M
Depreciation & Amortization 18.2 M
Capital Expenditures -27 M
Stock-Based Compensation 7.43 M
Change in Working Capital 14.3 M
Others 64.1 M
Free Cash Flow -30.2 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Inogen, Inc.
image
INGN has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Inogen, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
85.6 K USD 1
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
6 months ago
May 10, 2024
Sell 85.6 K USD
Somer Jason
EVP, Gen. Counsel & Secretary
- 10000
8.56 USD
2 years ago
Sep 01, 2022
Sell 44.4 K USD
Glezer Stanislav
EVP, Chief Technology Officer
- 1576
28.16 USD
2 years ago
Sep 01, 2022
Sell 32.2 K USD
Somer Jason
EVP, Gen. Counsel & Secretary
- 1145
28.16 USD
2 years ago
Mar 03, 2022
Sell 157 K USD
Anderson Ray Benjamin M
director:
- 4516
34.6809 USD
3 years ago
Dec 15, 2020
Sell 175 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 4449
39.439 USD
3 years ago
Dec 15, 2020
Sell 77 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 1904
40.42 USD
3 years ago
Dec 15, 2020
Sell 97.1 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 2349
41.33 USD
3 years ago
Sep 15, 2021
Sell 196 K USD
Huggenberger Raymond
Director
- 4000
49 USD
3 years ago
Sep 15, 2021
Sell 196 K USD
Huggenberger Raymond
Director
- 4000
49 USD
3 years ago
Aug 16, 2021
Sell 61.4 K USD
Huggenberger Raymond
Director
- 1000
61.3644 USD
3 years ago
Aug 16, 2021
Sell 187 K USD
Huggenberger Raymond
Director
- 2990
62.7013 USD
3 years ago
Aug 16, 2021
Sell 165 K USD
Huggenberger Raymond
Director
- 2604
63.188 USD
3 years ago
Aug 02, 2021
Sell 112 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 1397
80.3262 USD
3 years ago
Jul 30, 2021
Sell 659 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 8235
80.0149 USD
3 years ago
Jul 27, 2021
Sell 596 K USD
Taylor Brenton
EVP, Engineering
- 7942
75.0199 USD
3 years ago
Jul 27, 2021
Sell 723 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 9632
75.0171 USD
3 years ago
Jul 15, 2021
Sell 449 K USD
Huggenberger Raymond
Director
- 6822
65.8111 USD
3 years ago
Jul 15, 2021
Sell 11.9 K USD
Huggenberger Raymond
Director
- 178
66.62 USD
3 years ago
Jun 15, 2021
Sell 255 K USD
Huggenberger Raymond
Director
- 4000
63.8656 USD
3 years ago
Jun 15, 2021
Sell 197 K USD
Huggenberger Raymond
Director
- 3087
63.7349 USD
3 years ago
Jun 02, 2021
Sell 39 M USD
Novo Holdings A/S
10 percent owner
- 680000
57.32 USD
3 years ago
Apr 15, 2021
Sell 185 K USD
Taylor Brenton
EVP, Engineering
- 2841
65.2065 USD
3 years ago
Apr 14, 2021
Sell 368 K USD
Taylor Brenton
EVP, Engineering
- 6104
60.2207 USD
3 years ago
Apr 13, 2021
Sell 110 K USD
Taylor Brenton
EVP, Engineering
- 1838
60 USD
3 years ago
Apr 13, 2021
Sell 72 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 1200
60.0017 USD
3 years ago
Apr 14, 2021
Sell 98.7 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 1641
60.1366 USD
3 years ago
Apr 13, 2021
Sell 72 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 1200
60.0017 USD
3 years ago
Apr 14, 2021
Sell 98.7 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 1641
60.1366 USD
3 years ago
Mar 17, 2021
Sell 318 K USD
Taylor Brenton
EVP, Engineering
- 6200
51.2111 USD
3 years ago
Mar 17, 2021
Sell 445 K USD
Taylor Brenton
EVP, Engineering
- 8565
51.9377 USD
3 years ago
Mar 15, 2021
Sell 210 K USD
Myers Byron
EVP, Marketing
- 4050
51.7759 USD
3 years ago
Mar 15, 2021
Sell 159 K USD
Myers Byron
EVP, Marketing
- 3052
52.2137 USD
3 years ago
Mar 15, 2021
Sell 603 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 11586
52.0127 USD
3 years ago
Mar 15, 2021
Sell 343 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 6512
52.6103 USD
3 years ago
Mar 03, 2021
Sell 553 K USD
Taylor Brenton
EVP, Engineering
- 11562
47.848 USD
3 years ago
Mar 03, 2021
Sell 124 K USD
Taylor Brenton
EVP, Engineering
- 2560
48.553 USD
3 years ago
Mar 03, 2021
Sell 31.8 K USD
Taylor Brenton
EVP, Engineering
- 643
49.4086 USD
3 years ago
Mar 01, 2021
Sell 38.7 M USD
Novo Holdings A/S
10 percent owner
- 790000
49 USD
3 years ago
Feb 16, 2021
Sell 936 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 17398
53.8278 USD
3 years ago
Feb 16, 2021
Sell 936 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 17398
53.8278 USD
3 years ago
Feb 16, 2021
Sell 38.6 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 700
55.185 USD
3 years ago
Feb 16, 2021
Sell 38.6 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 700
55.185 USD
3 years ago
Feb 09, 2021
Sell 494 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 8973
55.0583 USD
3 years ago
Feb 01, 2021
Sell 664 K USD
Taylor Brenton
EVP, Engineering
- 13366
49.6575 USD
3 years ago
Feb 01, 2021
Sell 70.1 K USD
Taylor Brenton
EVP, Engineering
- 1398
50.1145 USD
3 years ago
Jan 26, 2021
Sell 397 K USD
Taylor Brenton
EVP, Engineering
- 7942
50.022 USD
3 years ago
Jan 26, 2021
Sell 449 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 8973
50.0353 USD
3 years ago
Jan 15, 2021
Sell 707 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 15966
44.2761 USD
3 years ago
Jan 15, 2021
Sell 95.6 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 2132
44.833 USD
3 years ago
Jan 08, 2021
Sell 263 K USD
Taylor Brenton
EVP, Engineering
- 5715
46.1034 USD
3 years ago
Jan 08, 2021
Sell 198 K USD
Taylor Brenton
EVP, Engineering
- 4202
47.1346 USD
3 years ago
Jan 08, 2021
Sell 53.2 K USD
Taylor Brenton
EVP, Engineering
- 1100
48.3339 USD
3 years ago
Dec 15, 2020
Sell 175 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 4449
39.439 USD
3 years ago
Dec 15, 2020
Sell 77 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 1904
40.42 USD
3 years ago
Dec 15, 2020
Sell 97.1 K USD
Bauerlein Alison
EVP, Finance, & CFO
- 2349
41.33 USD
5 years ago
Sep 04, 2019
Bought 42.9 K USD
McFarland Loren L
Director
+ 1000
42.9306 USD
5 years ago
Aug 15, 2019
Bought 86 K USD
Lukatch Heath
Director
+ 2000
43.01 USD
5 years ago
Jan 15, 2019
Sell 906 K USD
Huggenberger Raymond
Director
- 6649
136.24 USD
5 years ago
Jan 15, 2019
Sell 137 K USD
Huggenberger Raymond
Director
- 995
137.95 USD
5 years ago
Jan 15, 2019
Sell 79.8 K USD
Huggenberger Raymond
Director
- 574
139.11 USD
5 years ago
Jan 15, 2019
Sell 39.9 K USD
Huggenberger Raymond
Director
- 282
141.66 USD
5 years ago
Dec 14, 2018
Sell 235 K USD
Huggenberger Raymond
Director
- 1820
128.88 USD
5 years ago
Dec 14, 2018
Sell 244 K USD
Huggenberger Raymond
Director
- 1878
130.12 USD
5 years ago
Dec 14, 2018
Sell 426 K USD
Huggenberger Raymond
Director
- 3252
130.95 USD
5 years ago
Dec 14, 2018
Sell 204 K USD
Huggenberger Raymond
Director
- 1550
131.62 USD
6 years ago
Nov 15, 2018
Sell 158 K USD
Huggenberger Raymond
Director
- 1240
127.34 USD
6 years ago
Nov 15, 2018
Sell 222 K USD
Huggenberger Raymond
Director
- 1728
128.66 USD
6 years ago
Nov 15, 2018
Sell 500 K USD
Huggenberger Raymond
Director
- 3868
129.2 USD
6 years ago
Nov 15, 2018
Sell 252 K USD
Huggenberger Raymond
Director
- 1933
130.36 USD
6 years ago
Nov 15, 2018
Sell 105 K USD
Huggenberger Raymond
Director
- 800
131.64 USD
7. News
INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up Inogen's overall third-quarter 2024 results continue to gain from higher business-to-business sales. zacks.com - 5 days ago
Inogen, Inc. (INGN) Q3 2024 Earnings Call Transcript Call Start: 17:00 January 1, 0000 5:26 PM ET Inogen, Inc. (NASDAQ:INGN ) Q3 2024 Earnings Conference Call November 7, 2024, 5:00 PM ET Company Participants Ryan Peterson - Investor Relations Kevin Smith - President and CEO Mike Bourque - Chief Financial Officer Conference Call Participants Rohin Patel - JPMorgan Mike Matson - Needham Operator Welcome to Inogen's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. seekingalpha.com - 1 week ago
Inogen (INGN) Reports Q3 Earnings: What Key Metrics Have to Say While the top- and bottom-line numbers for Inogen (INGN) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com - 1 week ago
Inogen (INGN) Reports Q3 Loss, Tops Revenue Estimates Inogen (INGN) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $1.97 per share a year ago. zacks.com - 1 week ago
Here's Why You Should Retain Inogen Stock in Your Portfolio Now Expanding product portfolio and high prospects for POC raise optimism for INGN stock. zacks.com - 4 weeks ago
Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024 GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #COPD--Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024. businesswire.com - 1 month ago
Inogen Stock Rises 47% in 6 Months: What's Driving the Rally? INGN shows impressive momentum, driven by strong sales growth, an expanding product portfolio and significant advancements in portable oxygen technology. zacks.com - 1 month ago
Here's Why You Should Add Inogen Stock to Your Portfolio Now Expanding product portfolio and high prospects for POC raise optimism for the INGN stock. zacks.com - 2 months ago
Inogen (INGN) Rises 127% Year to Date: What's Driving the Stock? Expanding product portfolio and high prospects for POC raise optimism for the Inogen (INGN) stock. zacks.com - 2 months ago
Inogen (INGN) Reports Q2 Earnings: What Key Metrics Have to Say Although the revenue and EPS for Inogen (INGN) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 3 months ago
Inogen (INGN) Q2 Earnings Beat Estimates, Revenues Rise Y/Y Inogen's (INGN) second-quarter 2024 results reflect significant improvement in the top and bottom lines, driven by strong international and domestic business-to-business sales. zacks.com - 3 months ago
Inogen, Inc. (INGN) Q2 2024 Earnings Call Transcript Inogen, Inc. (NASDAQ:INGN ) Q2 2024 Earnings Conference Call August 6, 2024 5:00 PM ET Company Participants Ryan Peterson - IR Kevin Smith - President and CEO Mike Bourque - CFO Conference Call Participants Lilia-Celine Lozada - JPMorgan James Beer - William Blair Colin Clark - Stifel Michael Matson - Needham & Company Operator Welcome to Inogen's Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, August 6, 2024. seekingalpha.com - 3 months ago
8. Profile Summary

Inogen, Inc. INGN

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 239 M
Dividend Yield 0.00%
Description Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Contact 301 Coromar Drive, Goleta, CA, 93117 https://www.inogen.com
IPO Date Feb. 14, 2014
Employees 834
Officers Dr. Krishna Jhaveri Chief Medical Officer Ms. Jennifer Yi Boyer Executive Vice President & Chief Human Resources Officer Mr. Adrien Mithalal Senior Vice President of Research & Development Mr. Grgoire Ramade Executive Vice President & Chief Commercial Officer Mr. Paul Andreassi Senior Vice President of Quality & Regulatory Affairs Mr. Kevin R. M. Smith President, Chief Executive Officer & Director Mr. Philip Corrin Senior Vice President of Operations & Supply Chain Mr. Kevin P. Smith General Counsel & Executive Vice President of Business Development